Ontology highlight
ABSTRACT:
SUBMITTER: Zhang Q
PROVIDER: S-EPMC9210814 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
Zhang Qing Q Zhang Wenlong W Lin Tingsheng T Lu Wenfeng W He Xin X Ding Yuanzhen Y Chen Wei W Diao Wenli W Ding Meng M Shen Pingping P Guo Hongqian H
BMC cancer 20220620 1
Immunotherapy has emerged as a robust clinical strategy for cancer treatment. PD1/PD-L1 inhibitors have been used as second-line therapy for urothelial carcinoma due to the high tumor mutational burden. Despite the efficacy of the treatment is significant, the response rate is still poor. The tumor immune microenvironment plays a key role in the regulation of immunotherapeutic efficacy. However, a comprehensive understanding of the intricate microenvironment in clinical samples remains unclear. ...[more]